Skip to main content

Life Technologies Gets Japan OK for 7500 Fast Dx, 3500 Dx Instruments

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today announced that it has received marketing clearance in Japan for its 7500 Fast Dx Real-Time PCR instrument and 3500 Dx Series Genetic Analyzer.

The firm said that it filed the platforms were filed as diagnostic application instruments with the Tokyo Metropolitan Government in March. It plans to sell the systems in Japan for in vitro diagnostic use.

Life Tech said that clinical labs and institutions in Japan developing molecular diagnostics for oncology, genetic diseases, and infectious diseases would now be able to use the 7500 Fast Dx system to develop tests for clinical applications. The 3500 Dx Series, a capillary electrophoresis system for nucleic acid analysis, is intended for analyzing DNA or RNA for the detection of genetic changes that may lead to disease presence or susceptibility.

"These devices will enable physicians and laboratories to rapidly develop new clinical and diagnostic assays using a platform they are familiar with," Joydeep Goswami, head of Life Technologies Japan, said in a statement. "We will work closely with the developers of these assays to assist them in bringing their assays to patients quickly and safely."

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.